BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30400978)

  • 1. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective contracting and channelling patients to preferred providers: A scoping review.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Policy; 2017 May; 121(5):504-514. PubMed ID: 28381338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer.
    van der Hulst FJP; Brabers AEM; de Jong JD
    BMC Health Serv Res; 2023 Jan; 23(1):52. PubMed ID: 36653840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health plan choice in the Netherlands: restrictive health plans preferred by young and healthy individuals.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Econ Policy Law; 2017 Jul; 12(3):345-362. PubMed ID: 28290918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which preferred providers are really preferred? Effectiveness of insurers' channeling incentives on pharmacy choice.
    Boonen LH; Schut FT; Donkers B; Koolman X
    Int J Health Care Finance Econ; 2009 Dec; 9(4):347-66. PubMed ID: 19242791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
    Bes RE; van den Berg B
    Patient; 2013; 6(2):75-80. PubMed ID: 23549928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred Primary Healthcare Provider Choice Among Insured Persons in Ashanti Region, Ghana.
    Boachie MK
    Int J Health Policy Manag; 2015 Oct; 5(3):155-63. PubMed ID: 26927586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands.
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2022 Feb; 126(2):122-128. PubMed ID: 35000802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?
    van der Hulst FJP; Holst L; Brabers AEM; de Jong JD
    Health Policy; 2022 Jul; 126(7):693-703. PubMed ID: 35644719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting preferences for social health insurance in Ethiopia: a discrete choice experiment.
    Obse A; Ryan M; Heidenreich S; Normand C; Hailemariam D
    Health Policy Plan; 2016 Dec; 31(10):1423-1432. PubMed ID: 27418653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How is enrollees' trust in health insurers associated with choosing health insurance?
    van der Hulst FJP; Brabers AEM; de Jong JD
    PLoS One; 2023; 18(11):e0292964. PubMed ID: 37917768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical service provider networks.
    Mougeot M; Naegelen F
    Health Econ; 2018 Aug; 27(8):1201-1217. PubMed ID: 29774623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectations of clients, insurers, and providers: a qualitative responsiveness assessment among private health insurance sector in Kampala-Uganda.
    Tindyebwa T; Ssempala R; Ssennyonjo A; Mayora C; Muhoozi M; Tusabe J; Mukama P; Freddie S
    BMC Health Serv Res; 2023 Dec; 23(1):1358. PubMed ID: 38053178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.